U.S. International Development Finance Corporation

Activity by year

202120222023202420252026

Expansion

Oct 25, 2021EXPANSIONHyderabad, India, India$50.0Mops 2022
Biological E. expands vaccine facility in Hyderabad with $50M DFC financing
Biological E. Limited finalized a $50 million financing arrangement with the U.S. International Development Finance Corporation to expand its COVID-19 vaccine manufacturing facility in Hyderabad, India. The expansion aims to support production of more than one billion vaccine doses by end of 2022.
Biological E. Limited U.S. International Development Finance Corporation investor #Medical Devices dfc.gov

Loading…